Microcarrier Market by 2026 - Global Trends, Share Analysis, Leading Players, Business Opportunities

The microcarrier market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period.

Rising demand for cell-based vaccines;

The growth in population, climate change, and increasing contact between humans and animals have increased the threat of new virus outbreaks. Influenza and COVID-19, for example, have proven unpredictable and recurring events that pose a significant economic and social burden. As of March 10, 2021, 117.33 million cases of COVID-19 were confirmed globally, including 2.61 million deaths, by the WHO. The increasing incidence of infectious diseases and the growing risk of pandemics are expected to drive vaccine demand worldwide.

In the pharmaceutical industry, cell culture is increasingly becoming a prominent part of vaccine production. Earlier, vaccines were manufactured by growing and harvesting viruses in chicken eggs, a time-consuming process. In this regard, cell-based vaccine production has emerged as a far more efficient method due to its shortened lead-time and the capability to produce vaccines in larger quantities as per demand. In addition to these benefits, clinical trials have proved that cell-based vaccines are as effective, safe, and efficacious as egg-based vaccines.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=139831731&utm_source=openpr&utm_medium=referral

By product, the consumables segment accounted for the largest share of the microcarrier market in 2020.

Based on product, the microcarriers market is segmented into consumables and equipment. Consumables dominated the market in 2020. The large share of this segment can be attributed to the repeated purchase of high amounts of media for various applications.

By application, the biopharmaceutical production segment accounted for the largest share of the microcarrier market in 2020.

Based on application, the microcarriers market is categorized into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other applications. The biopharmaceutical production application segment dominated the market in 2020. The large share of the biopharmaceutical production segment can be attributed to increasing commercial expansion of major pharmaceutical companies and increasing demand for monoclonal antibodies.

By end user, the pharmaceutical and biotechnology companies segment accounted for the largest share of the microcarrier market in 2020.

Based on end users, the microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, academic and research institutes, and cell banks Pharmaceutical & biotechnology companies dominated the market in 2020. The large share of this segment can be attributed to rising awareness about the benefits of cell-based vaccines and growing regulatory approvals for cell-based vaccines.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=139831731&utm_source=openpr&utm_medium=referral

North America accounted for the largest share of the microcarrier market in 2020.

In 2020, North America accounted for the largest share of the microcarriers market, followed by Europe. The large share of the North American regional segment can be attributed to rising R&D into biologics and gene therapies, technological advancements, and investments in cell-based research.

Key Market Players;

Thermo Fisher Scientific (US), Merck KGaA (Germany), Sartorius AG (Germany) and Danaher Corporation (US) are the prominent players operating in the microcarrier market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139831731&utm_source=openpr&utm_medium=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.